Your healthcare provider has ordered blood tests to check your liver because some patients experienced increased liver blood test values and liver problems while taking VEOZAH. During clinical trials 2.3% of women taking VEOZAH versus 0.9% of women taking placebo experienced increased liver blood test levels. Levels returned to pretreatment levels (or close to these) with dose continuation or upon dose interruption, or discontinuation. Since VEOZAH became available, a patient taking VEOZAH experienced serious liver problems. The patient's signs and symptoms gradually resolved after stopping use of VEOZAH.
Your healthcare provider will do a blood test to check your liver before you start taking VEOZAH, monthly for the first 3 months, at month 6, and month 9 after you start taking VEOZAH or if you have signs or symptoms that suggest liver problems. If your liver blood test values are elevated, your healthcare provider may advise you to stop treatment or request additional liver blood tests. Stop VEOZAH and call your healthcare provider right away if you have any of the following signs or symptoms of liver problems: feeling more tired than you do usually, nausea, vomiting, itching, yellowing of the eyes or skin (jaundice), pale feces, dark urine, or pain in the upper right stomach (abdomen).